Toxicon

First international congress on envenomations and their treatments
pp. 141-142(2)
Authors: Goyffon M.; Bon C.

The serum-therapie was discovered 100 years ago.
pp. 142-143(2)
Author: Bon C.

Venomous snake systematics: implications for snakebite treatment and toxinology.
pp. 143-143(1)
Author: Wuster W.

New epidemiological aspects of scorpionism.
pp. 143-143(1)
Author: Goyffon M.

Venomous sea creatures: significance as human health hazards.
pp. 143-143(1)
Author: Mebs D.

Experience of envenomation at the Marseille Poison Centre.
pp. 143-143(1)
Author: Jouglard J.

Poisonous snakes, ecological disturbances and public health.
pp. 144-144(1)
Authors: Melgarejo A.R.; Aguiar A.S.

Ecology of Echis ocellatus and peri-urban bites in Ouagadougou.
pp. 144-144(1)
Author: Revault P.

Scorpionism, life history strategies and parthenogenesis.
pp. 144-144(1)
Authors: Lourenco W.R.; Cuellar O.; Cloudsley-Thompson J.L.; Eickstedt V.R.D.; Barraviera B.

Clinical features of envenoming from snakebites.
pp. 144-144(1)
Author: Warrell D.A.

Clinical and biological evaluation of viper bites.
pp. 145-145(1)
Authors: Sorkine M.; Audebert F.; Bon C.

Snakebite severity score.
pp. 145-145(1)
Authors: Dart R.; Hurlbut K.; Garcia R.; Boren J.

Clinical aspects of envenomation by marine animals.
pp. 145-145(1)
Authors: Fenner P.J.; Williamson J.A.; Burnett J.W.

Myocardial effects of envenoming by elapids in Papua New Guinea.
pp. 145-146(2)
Authors: Lalloo D.G.; Trevett A.J.; Nwokolo N.; Naraqi S.; Kevau I.; Kemp M.; Hooper R.J.L.; Theakston R.D.G.; Warrell D.A.

Acquired haemorrhagic syndrome from contact with a caterpillar (Lonomia obliqua Walker 1855, Saturniidae).
pp. 146-146(1)
Authors: Kelen E.M.A.; Duarte A.C.; Tomy S.C.; Sano-Martins I.S.; Castro S.C.B.; Guerrero B.; Arocha-Pinango C.L.

Biodynamics of in vivo antigen-antibody neutralization.
pp. 146-146(1)
Author: Scherrmann J.M.

The kinetics of snakebite envenoming and therapy.
pp. 146-146(1)
Author: Theakston R.D.G.

Toxicokinetics of envenomations and antivenom therapy.
pp. 147-147(1)
Authors: Choumet V.; Audebert F.; Riviere G.; Sorkine M.; Sabouraud A.; Urtizberea M.; Scherrmann J.M.; Bon C.

Clearing of circulating whole venom, crotoxin and crotamine antigens after specific serotherapy in patients envenomed by Crotalus durissus snakebite.
pp. 147-147(1)
Authors: Amaral C.F.S.; Diniz C.R.; Chavez-Olortegui C.; Penaforte C.L.; Campolina D.; Dias M.B.; Rezende N.A.

Serotherapy of scorpion envenoming: pharmacokinetics of antivenoms and a critical assessment of their usefulness.
pp. 147-147(1)
Authors: Ismail M.; Abd-Elsalam M.A.

Brazilian program for envenomation treatment.
pp. 148-148(1)
Author: Raw I.

Preparation of improved F(ab')₂ antivenoms. An example: new polyvalent anti-European vipers (equine).
pp. 148-148(1)
Authors: Grandgeorge M.; Veron J.L.; Lutsch C.; Makula M.F.; Riffard P.; Pepin S.; Scherrmann J.M.

Development of novel antivenoms based on specific ovine Fab.
pp. 148-148(1)
Authors: Landon J.; Smith D.C.

Molecular immunology of a snake toxin.
pp. 148-148(1)
Authors: Menez A.; Leonetti M.; Maillere B.; Boulain J.-C.

Isolation of a non-toxic protein from the venom of the Brazilian scorpion Tityus serrulatus (Lutz and Mello, 1923) that induces the production of antivenoms in mammals.
pp. 149-149(1)
Author: Diniz C.R.

Multidisciplinary approach for immunoprevention of scorpion envenomation.
pp. 149-149(1)
Authors: El Ayeb M.; Zenouaki I.; Bouhaouala B.; Karoui H.; Kharrat R.; Ducancel F.; Boulain J.C.; Menez A.; Sabatier J.M.; Mabrouk K.; Devaux C.; van Rietschoten J.; Rochat H.

Molecular properties of scorpion toxins in relation to the treatment of scorpion envenomation.
pp. 149-149(1)
Authors: Rochat H.; Guieu R.; Devaux C.

Evaluation of the neutralizing ability of antivenoms for the treatment of snakebite envenomations in Central America.
pp. 149-150(2)
Authors: Gutierrez J.M.; Rojas G.; Bogarin G.; Lomonte B.

A new procedure for inducing higher titres of antibody in curative sera: clonal expansion followed by stimulation with exponential dose of same toxoid.
pp. 150-150(1)
Authors: Heneine I.F.; Heneine L.G.D.; Daniel J.P.; Nascimento M.C.S.; Rocha O.A.

Neutralizing ability of IgG(T) and IgGa subclasses isolated from anti-bothropic horse serum.
pp. 150-150(1)
Authors: Takehara H.A.; Fernandes I.; Cormont F.; Latinne D.; Bazin H.; Mota I.

Evolution of snake venom toxins.
pp. 150-151(2)
Authors: Da Silva A.M.M.; Theakston R.G.D.; Crampton J.M.

Envenomation and treatment of bites by venomous snakes in the United States.
pp. 151-151(1)
Author: Russell F.E.

Snake envenomation treatment in tropical Africa.
pp. 151-151(1)
Authors: Chippaux J.P.; Amadi-Eddine S.; Fagot P.; Rage V.; Lang J.

Bothrops lanceolatus bites in Martinique: clinical aspects and treatment.
pp. 151-151(1)
Authors: Research Group on Snakebite in Martinique; Thomas L.; Tyburn B.

Clinical features and treatment principles in envenoming by European vipers.
pp. 151-152(2)
Authors: Persson H.; Karlson-Stiber C.

Specific sheep Fab fragments in the treatment of Vipera berus envenoming. Report of a multicentre study.
pp. 152-152(1)
Authors: Karlson-Stiber C.; Persson H.; Heath A.; Smith D.; Abdullah I.A.

Tolerance study of the antivenom IPSER Europe F(ab')₂ given as an intravenous infusion to patients poisoned by European vipers: preliminary results for 1994 season.
pp. 152-152(1)
Authors: SVE Study Investigators; De Haro L.; Marchal F.; Lang J.; Jouglard J.

Evolution of some biological parameters during viper envenomations treated with Ipser Afrique antivenom.
pp. 152-153(2)
Authors: Fagot P.; Amadi-Eddie S.; Rage V.; Lang J.; Chippaux J.P.

Pathogenesis of severe bites by certain pit vipers in Asia, and antivenom therapy.
pp. 153-153(1)
Authors: Sawai Y.; Sakai A.; Kawamura Y.

Life-supporting measures in intensive care units: an alternative to antiserum in snakebites.
pp. 153-153(1)
Authors: Salib P.; Baud J.F.; Goyffon M.

Electric shock therapy and snake extractors: alternative devices in the treatment of venomous snakebites.
pp. 153-153(1)
Author: Gold B.S.

Treatment of scorpion envenomation in Brazil.
pp. 153-154(2)
Authors: Freire-Maia L.; Campos J.A.; Amaral C.F.S.

Scorpion stings in Mexico and their treatment.
pp. 154-154(1)
Authors: Calderon-Aranda E.S.; Dehesa-Davila M.; Chavez-Haro A.; Possani L.

Clinical manifestations do not disappear promptly after circulating venom neutralization by specific serotherapy in patients envenomed by Tityus serrulatus scorpions.
pp. 154-154(1)
Authors: Rezende N.A.; Diniz C.R.; Campolina D.; Dias M.B.; Chavez-Olortegui C.; Amaral C.F.S.

Clinical management of spiderbite.
pp. 155-155(1)
Author: White J.

Multi-tentacled box jellyfish (chirodropid) marine envenomation worldwide: rationale of clinical management.
pp. 155-155(1)
Authors: Williamson J.A.; Fenner P.J.; Burnett J.W.; Rifkin J.F.

Contribution of the Societe de Pathologie Exotique to the diffusion of knowledge concerning envenomations and their treatments.
pp. 155-155(1)
Authors: Chippaux A.; Baltazard S.

Indian medicinal plants active against Elapidae and Viperidae snake venoms.
pp. 155-156(2)
Authors: Alam M.I.; Gomes A.

Results of 3 years of antiscorpionic programme in a pilot zone of South Algeria (Biskra).
pp. 156-156(1)
Authors: Alamir B.; Hamdi-Aissa L.; Ouahdi M.; Benguedda A.C.; Guerinik M.; Merad R.

A novel antivenom raised against venom from the desert black cobra (Walterinnesia aegyptia).
pp. 156-156(1)
Authors: Al-Asmari A.; Sjostrom L.; Al-Abdulla I.; Smith D.C.

Peritoneal dialysis in scorpion sting (192 cases).
pp. 156-156(1)
Authors: Azek S.; Amri F.; Fejji S.; Makni R.; Sboui E.; Troudi M.; Kharrat H.

Inflammatory cytokines and scorpionic envenomation: analysis of serological levels in 46 Tunisian patients.
pp. 156-157(2)
Authors: Barbouche M.R.; Haguiga H.; Nouira S.; Krifi M.N.; Abroug F.; Bouchoucha S.; Dellagi K.

Fatalities due to viper-bite in Italy in the years 1951-1991.
pp. 157-157(1)
Author: Beer E.

Insulinaemia after grave envenomation by scorpion stings (GESS).
pp. 157-157(1)
Authors: Bouaziz M.; Bellasoued M.; Zeghal K.; Hamida C.B.; Zebidi A.; Jeddi H.M.

Cardiac dysfunction (CD) and pulmonary oedema (PE) following severe scorpion envenomation (SSE).
pp. 157-157(1)
Authors: Bouaziz M.; Hamida C.B.; Triki S.; Rekik N.; Jeddi H.M.

Study of atrio-ventricular conduction by registration of his potential after grave envenomation by scorpion stings (GESS).
pp. 157-157(1)
Authors: Bouaziz M.; Hamida C.B.; Guetat N.; Rekik N.; Brigui; Jeddi H.M.

Electrocardiogram (ECG) after severe scorpion sting (104 cases).
pp. 157-158(2)
Authors: Bouaziz M.; Guetat N.; Chelly H.; Triki S.; Jeddi H.M.

Neuromuscular block after Naja envenomation.
pp. 158-158(1)
Authors: Bouaziz M.; Hamida C.B.; Chaari M.; Rekik N.; Jeddi H.M.

Development of a sandwich ELISA test for the determination of venom levels in the serum of patients bitten by Bothrops lanceolatus.
pp. 158-158(1)
Authors: Groupe de Recherche sur la Morsure de Serpent en Martinique; Canonge D.; Choumet V.; Robbe-Vincent A.; Saliou B.; Bon C.

Hospital Vital Brazil: 50 years of clinical experience at Instituto Butantan, Sao Paulo.
pp. 158-158(1)
Author: Cardoso J.L.C.

Identification of species-specific components in bothropic venoms.
pp. 158-159(2)
Authors: Catty D.; Heneine L.G.D.

Development of ELISA tests for the detection of Brazilian snakes, scorpions and spiders venom antigens.
pp. 159-159(1)
Authors: Chavez-Olortegui C.; Penaforte C.; Guatimosim S.; Ferreira A.; Diniz C.

Clinical aspects of simuliidosis in the area of Vaucluse, France.
pp. 159-159(1)
Authors: Chevrier S.; Beaucournu-Saguez F.; Ungeheuer M.N.; Beaucournu J.C.

Drugs and plants which antagonize venom or potentiate antivenom.
pp. 159-160(2)
Authors: Chippaux J.-P.; Rakotonirina V.S.; Rakotonirina A.; Dzikouk G.

Viper envenomation and serotherapy.
pp. 160-160(1)
Authors: Chouaki M.; Menage F.; Claud B.; Tourret J.

Preclinical assessment of a new ovine brown snake (Pseudonaja sp.) antivenom.
pp. 160-160(1)
Authors: Crouch R.G.; Smith D.C.; Lee L.; Jones R.G.

Latrodectism in Madagascar and in France: comparison of series collected in the Poison Centre of Marseille and in the Tananarive Medical Intensive Care Unit.
pp. 160-160(1)
Authors: De Haro L.; Ramialiharisoa A.; Jouglard J.; David J.M.

Epidemiology of scorpion envenomations in Brazil.
pp. 160-161(2)
Authors: Fan H.W.; Cardoso J.L.C.; Araujo F.A.A.

Lack of efficacy of antihistamine in preventing early reactions to horse antivenom administration: a retrospective study.
pp. 161-161(1)
Authors: Fan H.W.; Mendes L.P.; Franca F.O.S.; Cardoso J.L.C.

Neutralization of crotoxin by the specific crotoxin inhibitor from Crotalus durissus terrificus serum.
pp. 161-161(1)
Authors: Faure G.; Perales J.; Villela C.; Choumet V.; Saliou B.; Domont G.B.; Moussatche H.; Bon C.

Database for antivenoms to support fast supply and proper storage.
pp. 161-161(1)
Authors: Ganzert M.; Zilker T.H.; Hofmann A.; Felgenhauer N.; Altes M.K.

Comparative evaluation of chemical antagonists against Indian viper and cobra venom.
pp. 161-162(2)
Authors: Gomes A.; Alam M.I.

Envenomations registered at Algiers CAP: schedule of 4 years 1991-1994.
pp. 162-162(1)
Authors: Hamdi-Aissa L.; Alamir B.; Abtroun R.; Azzouz M.; Merad R.

Venom production for antisera: captive-born versus wild-caught specimens.
pp. 162-162(1)
Author: Harrison J.R.

Sir Joseph Fayrer of the Indian Medical Service: snakebite in India in the late 19th century.
pp. 162-162(1)
Author: Hawgood B.J.

Stepwise iodination: an easy method for rapidly preparing safe, inexpensive, stable and irreversible toxoids and venoids with strong immunogenic properties.
pp. 162-163(2)
Authors: Heneine L.G.D.; Daniel J.P.; Nascimento M.C.S.; Rocha O.A.; Beraldo W.T.; Cassali G.D.; Heneine I.F.

Structure of non-toxic components of 300 kDa, 500 kDa, and 900 kDa progenitor toxins produced by Clostridium botulinum type A and D.
pp. 163-163(1)
Authors: Inoue K.; Ohyama T.; Watanabe T.; Fujinaga Y.; Inoue K.; Oguia K.

Histological and ultrastructural study of lung in pulmonary oedema (PE) after human grave envenomation by scorpion stings (GESS).
pp. 163-164(2)
Authors: Jeddi H.M.; Jeddi M.; Bouaziz M.; Rekik N.; Hamida C.B.; Chelly H.; Triki S.; Jaafoura H.

Rapid reversal of brown snake (Pseudonaja sp.) venom-induced neurotoxicity by a Fab-based antivenom.
pp. 164-164(1)
Authors: Jones R.G.A.; Smith D.C.

Treatment of envenomation after Echis ocellatus bites in Burkina Faso.
pp. 164-164(1)
Authors: Kabore J.; Revault P.

Selective proteolysis of platelet ₂₁ integrin (GPIa/IIa) by jararhagin, a haemorrhagic metalloproteinase from Bothrops jararaca venom.
pp. 164-164(1)
Authors: Kamiguti A.S.; Hay C.R.M.; Zuzel M.

Preparation and use of different immunogens for production of antiscorpionic immune sera.
pp. 164-165(2)
Authors: Kharrat R.; Zenouaki I.; Lasfar Z.B.; Miled K.; Karoui H.; El Ayeb M.

Immunoenzymatic assay of scorpion venoms: toxicokinetics of envenomation.
pp. 165-165(1)
Authors: Krifi N.M.; Dellagi K.; Choumet V.; Bon C.; El Ayeb M.

Development of an enzyme-linked immunosorbent assay (ELISA) for identification venoms from snakes in the Agkistrodon genus.
pp. 165-165(1)
Authors: Q. L.; Ownby C.

Lethal toxin neutralizing factor from opossum serum as a treatment for snakebites and various types of allergies.
pp. 165-165(1)
Author: Lipps B.V.

Pharmacological evaluation of mouse paw oedema induced by Bothrops lanceolatus venom.
pp. 165-166(2)
Authors: de Araujo A.L.; De Souza A.O.; Bon C.

Cross-reactivity testing of antivenoms: a way to improve snakebite treatment?
pp. 166-166(1)
Author: Mebs D.

Scorpionic envenomation declared in Algeria in 1993: a study of 15,843 cases.
pp. 166-166(1)
Authors: Ouahdi M.; Guerinik M.; Griene L.; Benguedda A.C.; Moumen A.; Merad R.; Alamir B.; Hamdi-Aissa L.; Azzouz M.; Benaissa D.

Clinical experience with a new Echis antivenom.
pp. 166-167(2)
Authors: Meyer W.P.; Habib A.G.; Onayade A.A.; Yakubu A.; Theakston R.D.G.; Warrell D.A.

Genetic origin of the variability of venoms: impact on the preparation of antivenoms.
pp. 167-167(1)
Authors: Nkinin S.W.; Pietin D.; Doljansky Y.; Tremeau O.; Menez A.; Chippaux J.-P.

Ability of six Latin American antivenoms to neutralize the venom of Mapana equis (Bothrops atrox) from Antioquia and Choco (Colombia).
pp. 167-167(1)
Authors: Posada L.E.; Otero R.; Nunez V.; Osorio R.G.; Gutierrez J.M.; Giraldo C.A.

Studies on the jellyfish Carybdea rastoni.
pp. 167-168(2)
Authors: Othman I.; Eldila M.T.; Mustaffa M.R.; Musa M.Y.; Norazila

Mortality by snakebite in Africa: a case study in rural Senegal.
pp. 168-168(1)
Authors: Pison G.; Trape J.F.

Differences in complement inactivation by venom from different rattlesnake (Crotalus) species.
pp. 168-168(1)
Authors: Rael E.D.; Meza J.; Maddux J.; Maddux N.

Production and assessment of a new coral snake (Micrurus fulvius fulvius) antivenom for North America.
pp. 168-168(1)
Authors: Rawat S.; Laing G.; Smith D.C.; Theakston R.D.G.; Landon J.

Treatment of adder (Vipera berus berus) envenoming with an ovine affinity purified Fab antivenom.
pp. 168-169(2)
Authors: Sjostrom L.; Karlson-Stiber C.; Persson H.; Al-Abdulla I.H.; Smith D.C.

Effect of nifedipine (l-type Ca channel blocker) and scorpion antivenom on rat cultured heart cells treated with venom of the yellow scorpion, Leiurus quinquestriatus.
pp. 169-169(1)
Authors: Sofer S.; Arie G.S.; Shainberg A.

A simple method to obtain pure venom from small spiders.
pp. 169-169(1)
Authors: Souza C.M.V.; Monnerat A.T.; Novellino K.V.A.; Queiroz A.P.; Paula P.; Melgarejo A.R.

Analysis and identification of snake venoms by mass spectrometry.
pp. 169-169(1)
Authors: Stocklin R.; Mebs D.

Protection of mice against envenomation by the funnel-web spider (Atrax robustus) with a retro-inverso peptide vaccine.
pp. 170-170(1)
Authors: Tyler M.I.; Comis A.; Fischer P.M.

Neostigmine in accidents caused by Micrurus frontalis.
pp. 170-170(1)
Authors: Vieira R.J.; Brazil O.V.

Necrotic arachnidism and its management: possible role for hyperbaric oxygen therapy.
pp. 170-170(1)
Authors: White J.; Williamson J.; Rieger N.; Borer R.; Angley C.

Subspecies and ages specialities of the venom of Bulgarian Vipera ammodytes populations.
pp. 170-170(1)
Authors: Zhelev Z.; Matev I.; Stanilova S.; Christov K.

Sir Joseph Fayrer MD FRS (1824-1907) Indian medical service: snakebite and mortality in British India
pp. 171-182(12)
Author: Hawgood B.J.

Synaptosomal binding of ¹²⁵I-labelled daboiatoxin, a new PLA₂ neurotoxin from the venom of daboia russelli siamensis
pp. 183-199(17)
Authors: Maung-Maung-Thwin; Yuen R.; Gopalakrishnakone P.; Tan C.H.

Pathological changes induced by an acidic phospholipase A₂ from ophiophagus hannah venom on heart and skeletal muscle of mice after systemic injection
pp. 201-211(11)
Authors: Min-zhou H.; Gopalakrishnakone P.

Facile production of native-like _K-bungarotoxin in yeast: an enhanced system for the production of a neuronal nicotinic acetylcholine receptor probe
pp. 213-224(12)
Authors: Fiordalisi J.J.; James P.L.; Yueping Z.; Grant G.A.

High incidence of bites and stings by snakes and other animals among rubber tappers and amazonian indians of the Jurua valley, Acre State, Brazil
pp. 225-236(12)
Authors: Pierini S.V.; Warrell D.A.; De Paulo A.; Theakston R.D.G.

Effect of 3,4-diaminopyridine on rat extensor digitorum longus muscle paralyzed by local injection of botulinum neurotoxin
pp. 237-249(13)
Authors: Adler M.; Macdonald D.A.; Sellin L.C.; Parker G.W.

Cloning and characterization of the genomic region encoding toxin IV-5 from the scorpion Tityus serrulatus lutz and mello
pp. 251-256(6)
Authors: Corona M.; Zurita M.; Possani L.D.; Becerril B.

New procedures and parameters for better evaluation of Androctonus australis garzonii (Aag) and Buthus occitanus tunetanus (Bot) scorpion envenomations and specific serotherapy treatment
pp. 257-266(10)
Authors: Naceur Krifi M.; El Ayeb M.; Dellagi K.

Immunochemical characterization of type a botulinum neurotoxin in its purified and complexed forms
pp. 267-275(9)
Authors: Ram Singh B.; Lopes T.; A. Silvia M.

The coronary vasoconstrictor action of extract IV from the dahlia sea anemone Tealia felina L.
pp. 277-282(6)
Authors: Konya R.S.; Elliott R.C.